Xbiotech Inc (XBIT)

$2.69 -0.03 (-1.10%)
Market Cap 82.93M
Revenue (ttm) 0.00
Net Income (ttm) -38.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 20,500
Avg Vol 46,344
Day's Range N/A - N/A
Shares Out 30.49M
Stochastic %K 0%
Beta 0.85
Analysts Strong Buy
Price Target $18.00

Company Profile

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inf...

Industry: Biotechnology
Sector: Healthcare
Phone: 512 386 2900
Fax: 512 386 5505
Address:
5217 Winnebago Lane, Austin, United States
GFstocktwits
GFstocktwits Sep. 10 at 10:17 AM
$XBIT https://pmc.ncbi.nlm.nih.gov/articles/PMC11364570/ re atopic dermatitis....not positive and the colorectal cancer phase 3 terminated
0 · Reply
baj10se
baj10se Sep. 9 at 1:05 PM
$XBIT added a bit yesterday as well
0 · Reply
theBigDollarski
theBigDollarski Sep. 8 at 6:32 PM
$XBIT loaded up again once more.....what gives with this company??
0 · Reply
bcobersee
bcobersee Sep. 8 at 6:17 PM
$XBIT added again
0 · Reply
BiotechAnalyst1
BiotechAnalyst1 Sep. 4 at 7:05 AM
$XBIT whats about…. Any ideas whats going on here? https://www.xbiotech.com/news/another-milestone-achieved-in-phase-i-clinical-trial-for-hutrukin-tm-stroke-drug
1 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 3 at 6:39 AM
$XBIT Outstanding article that hits the mark on XBIT's current state. So if you want to refresh your XBIT insights or learn about XBIT from scratch, this is a must read. https://beyondspx.com/quote/XBIT/xbiotech-unlocking-natural-immunity-amidst-financial-headwinds-nasdaq-xbit#analysis
0 · Reply
MarkZH
MarkZH Sep. 2 at 4:47 PM
$XBIT Start Phase III in Pancreatic coming soon - I believe !!
0 · Reply
baj10se
baj10se Sep. 1 at 1:36 PM
$XBIT whats next on this? **Pancreatic Cancer Study**: In June 2024, XBiotech reported promising results from a Phase 1/Phase 2 randomized, double-blind study for advanced pancreatic cancer. The study suggested that combining ONIVYDE/5-FU with their anti-IL-1alpha therapy could reduce toxicities and improve outcomes, positioning it as a potential breakthrough treatment.[](https://investors.xbiotech.com/press-releases)
1 · Reply
Trekingirl
Trekingirl Aug. 29 at 5:26 PM
$XBIT Bought a couple more today. Why not? Market Cap $100 Million. Cash $153 Million. Shares Outstanding 30,487,731. Insider Ownership somewhere between 36.61% and 42.08% depending if you're on Schwab, webull, fintel, or yahoo. Tute Owned somewhere between 10.58% and 12.39% depending where you look. Oh and the big giant facility on 50 acres next to downtown Austin, TX. Bought and paid for. No debt.
1 · Reply
MarkZH
MarkZH Aug. 26 at 6:44 PM
$XBIT The only way is up 🚀
0 · Reply
Latest News on XBIT
The Schall Law Firm Invites Shareholders With Losses In XBiotech Inc. To Join A Securities Fraud Investigation

Mar 2, 2025, 11:00 AM EST - 7 months ago

The Schall Law Firm Invites Shareholders With Losses In XBiotech Inc. To Join A Securities Fraud Investigation

The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into XBiotech Inc. For Securities Fraud

Feb 2, 2025, 11:00 AM EST - 8 months ago

The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into XBiotech Inc. For Securities Fraud

XBiotech Inc. (XBIT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jan 29, 2025, 10:00 AM EST - 8 months ago

XBiotech Inc. (XBIT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages XBiotech Inc. (XBIT) Shareholders to Inquire about Securities Investigation

Jan 28, 2025, 10:00 AM EST - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages XBiotech Inc. (XBIT) Shareholders to Inquire about Securities Investigation

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into XBiotech Inc. For Securities Fraud

Jan 27, 2025, 11:15 AM EST - 8 months ago

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into XBiotech Inc. For Securities Fraud

Bronstein, Gewirtz & Grossman, LLC Is Investigating XBiotech Inc. (XBIT) And Encourages Shareholders to Connect

Jan 27, 2025, 10:00 AM EST - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating XBiotech Inc. (XBIT) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Shareholders to Reach Out

Jan 26, 2025, 10:00 AM EST - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against XBiotech Inc. (XBIT) and Encourages Investors to Learn More About the Investigation

Jan 24, 2025, 10:00 AM EST - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against XBiotech Inc. (XBIT) and Encourages Investors to Learn More About the Investigation

XBiotech Inc. (XBIT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jan 23, 2025, 10:00 AM EST - 8 months ago

XBiotech Inc. (XBIT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating XBiotech Inc. (XBIT) And Encourages Investors to Connect

Jan 22, 2025, 10:00 AM EST - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating XBiotech Inc. (XBIT) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages XBiotech Inc. (XBIT) Stockholders to Inquire about Securities Investigation

Jan 21, 2025, 10:00 AM EST - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages XBiotech Inc. (XBIT) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against XBiotech Inc. (XBIT) and Encourages Stockholders to Learn More About the Investigation

Jan 19, 2025, 10:00 AM EST - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against XBiotech Inc. (XBIT) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages XBiotech Inc. (XBIT) Investors to Inquire about Securities Investigation

Jan 17, 2025, 10:00 AM EST - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages XBiotech Inc. (XBIT) Investors to Inquire about Securities Investigation

XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm

Jan 17, 2025, 5:19 AM EST - 8 months ago

XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Investors to Reach Out

Jan 16, 2025, 10:00 AM EST - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Investors to Reach Out

The Schall Law Firm Urges Shareholders With Losses To Join An Inquiry Into XBiotech Inc For Securities Fraud

Jan 15, 2025, 11:15 AM EST - 8 months ago

The Schall Law Firm Urges Shareholders With Losses To Join An Inquiry Into XBiotech Inc For Securities Fraud

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Stockholders to Reach Out

Jan 15, 2025, 10:00 AM EST - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Stockholders to Reach Out

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating XBiotech for potential violations of securities laws

Jan 14, 2025, 4:37 PM EST - 8 months ago

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating XBiotech for potential violations of securities laws

Bronstein, Gewirtz & Grossman, LLC Is Investigating XBiotech Inc. (XBIT) And Encourages Stockholders to Connect

Jan 14, 2025, 11:15 AM EST - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating XBiotech Inc. (XBIT) And Encourages Stockholders to Connect

The Schall Law Firm Urges Shareholders With Losses To Join A Securities Fraud Inquiry Into XBiotech Inc.

Jan 13, 2025, 9:15 PM EST - 8 months ago

The Schall Law Firm Urges Shareholders With Losses To Join A Securities Fraud Inquiry Into XBiotech Inc.

XBiotech Pauses Rheumatology program

Dec 23, 2024, 9:00 AM EST - 9 months ago

XBiotech Pauses Rheumatology program

What's Going On With Small-Cap Cancer Focused XBiotech On Tuesday?

Jun 18, 2024, 1:08 PM EDT - 1 year ago

What's Going On With Small-Cap Cancer Focused XBiotech On Tuesday?

XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer

Jun 18, 2024, 11:35 AM EDT - 1 year ago

XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer

XBiotech: Several Shots On Goal In Big Target Market Indications

May 24, 2024, 4:08 PM EDT - 1 year ago

XBiotech: Several Shots On Goal In Big Target Market Indications

XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus

Jan 4, 2024, 9:00 AM EST - 1 year ago

XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus

Dr. Alan Kivitz to Chair XBiotech's Natrunix Program in Rheumatoid Arthritis

Nov 14, 2023, 9:00 AM EST - 2 years ago

Dr. Alan Kivitz to Chair XBiotech's Natrunix Program in Rheumatoid Arthritis

XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke

Sep 26, 2023, 9:00 AM EDT - 2 years ago

XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke

XBiotech Announces Enrollment Completion of Phase II, Placebo Controlled, Multicenter Study for Natrunix in Pancreatic Cancer

Aug 30, 2023, 9:00 AM EDT - 2 years ago

XBiotech Announces Enrollment Completion of Phase II, Placebo Controlled, Multicenter Study for Natrunix in Pancreatic Cancer

XBiotech Announces First Patient Begins Novel Natrunix Therapy in Phase II Rheumatoid Arthritis (RA) Clinical Trial

Aug 8, 2023, 11:47 AM EDT - 2 years ago

XBiotech Announces First Patient Begins Novel Natrunix Therapy in Phase II Rheumatoid Arthritis (RA) Clinical Trial

GFstocktwits
GFstocktwits Sep. 10 at 10:17 AM
$XBIT https://pmc.ncbi.nlm.nih.gov/articles/PMC11364570/ re atopic dermatitis....not positive and the colorectal cancer phase 3 terminated
0 · Reply
baj10se
baj10se Sep. 9 at 1:05 PM
$XBIT added a bit yesterday as well
0 · Reply
theBigDollarski
theBigDollarski Sep. 8 at 6:32 PM
$XBIT loaded up again once more.....what gives with this company??
0 · Reply
bcobersee
bcobersee Sep. 8 at 6:17 PM
$XBIT added again
0 · Reply
BiotechAnalyst1
BiotechAnalyst1 Sep. 4 at 7:05 AM
$XBIT whats about…. Any ideas whats going on here? https://www.xbiotech.com/news/another-milestone-achieved-in-phase-i-clinical-trial-for-hutrukin-tm-stroke-drug
1 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 3 at 6:39 AM
$XBIT Outstanding article that hits the mark on XBIT's current state. So if you want to refresh your XBIT insights or learn about XBIT from scratch, this is a must read. https://beyondspx.com/quote/XBIT/xbiotech-unlocking-natural-immunity-amidst-financial-headwinds-nasdaq-xbit#analysis
0 · Reply
MarkZH
MarkZH Sep. 2 at 4:47 PM
$XBIT Start Phase III in Pancreatic coming soon - I believe !!
0 · Reply
baj10se
baj10se Sep. 1 at 1:36 PM
$XBIT whats next on this? **Pancreatic Cancer Study**: In June 2024, XBiotech reported promising results from a Phase 1/Phase 2 randomized, double-blind study for advanced pancreatic cancer. The study suggested that combining ONIVYDE/5-FU with their anti-IL-1alpha therapy could reduce toxicities and improve outcomes, positioning it as a potential breakthrough treatment.[](https://investors.xbiotech.com/press-releases)
1 · Reply
Trekingirl
Trekingirl Aug. 29 at 5:26 PM
$XBIT Bought a couple more today. Why not? Market Cap $100 Million. Cash $153 Million. Shares Outstanding 30,487,731. Insider Ownership somewhere between 36.61% and 42.08% depending if you're on Schwab, webull, fintel, or yahoo. Tute Owned somewhere between 10.58% and 12.39% depending where you look. Oh and the big giant facility on 50 acres next to downtown Austin, TX. Bought and paid for. No debt.
1 · Reply
MarkZH
MarkZH Aug. 26 at 6:44 PM
$XBIT The only way is up 🚀
0 · Reply
bcobersee
bcobersee Aug. 26 at 5:38 PM
$XBIT
0 · Reply
LYogi
LYogi Aug. 14 at 7:21 PM
$XBIT what's the bull thesis here?
1 · Reply
bcobersee
bcobersee Aug. 14 at 9:27 AM
$XBIT
0 · Reply
kshonstocks
kshonstocks Aug. 13 at 4:28 PM
$XBIT alert good chart spot
0 · Reply
baj10se
baj10se Aug. 5 at 2:17 PM
$XBIT well - they finally have a respectable sized board of directors.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 28 at 7:46 PM
$XBIT Outstanding article that hits the mark on XBIT's current state. So if you want to refresh your XBIT insights or learn about XBIT from scratch, this is a must read. https://beyondspx.com/article/xbiotech-unlocking-natural-immunity-amidst-financial-headwinds-nasdaq-xbit
0 · Reply
WallstreetGenie
WallstreetGenie Jun. 29 at 5:32 AM
$XBIT what’s the float on this
2 · Reply
bcobersee
bcobersee Jun. 28 at 7:57 AM
$XBIT more than 25x average daily volume yesterday… someone bought a lot! interesting… over 2.5 mio. shares traded
1 · Reply
bcobersee
bcobersee Jun. 27 at 8:41 PM
$XBIT
0 · Reply
bcobersee
bcobersee Jun. 26 at 7:53 PM
$XBIT rising volume… just a bit patience
0 · Reply
bcobersee
bcobersee Jun. 26 at 1:14 PM
$XBIT new 8K-file
0 · Reply
baj10se
baj10se Jun. 20 at 9:16 PM
$XBIT what a turd.
1 · Reply